Canadian Imperial Bank of Commerce
CM
Bank of Nova Scotia
BNS
The Toronto-Dominion Bank
TD
Bank of Montreal
BMO
Royal Bank of Canada
RY
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 82.96%-2.62K | 76.68%-12.71K | 86.93%-11.84K | 54.23%-162.62K | 98.91%-2.11K | -15.36K | 46.46%-54.52K | -49.02%-90.64K | -788.41%-355.32K | -1,443.95%-192.67K |
Net income from continuing operations | 87.49%-50.47K | 56.64%-44.53K | 65.10%-27.42K | -47.56%-500.13K | 147.44%84.75K | ---403.6K | -4.93%-102.71K | -25.93%-78.58K | -212.00%-338.93K | -103.03%-178.65K |
Asset impairment expenditure | ---- | ---- | ---- | --274.09K | ---65.16K | ---- | ---- | ---- | --0 | ---- |
Change In working capital | -2.30%47.86K | -33.97%31.82K | 229.19%15.58K | 486.92%63.42K | -54.76%-21.7K | --48.99K | 1,321.11%48.19K | -865.71%-12.06K | -689.14%-16.39K | -245.15%-14.02K |
-Change in receivables | -122.69%-1.96K | 371.08%7.46K | 40.77%-1.38K | 160.02%1.93K | 66.65%-1.62K | --8.63K | -134.69%-2.75K | 63.02%-2.33K | 41.11%-3.22K | -5.44%-4.86K |
-Change in payables and accrued expense | 23.44%49.82K | -52.18%24.36K | 274.19%16.96K | 566.75%61.49K | -119.27%-20.07K | --40.36K | 528.76%50.94K | -223.82%-9.74K | -259.77%-13.17K | -164.15%-9.16K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 82.96%-2.62K | 76.68%-12.71K | 86.93%-11.84K | 54.23%-162.62K | 98.91%-2.11K | ---15.36K | 46.46%-54.52K | -49.02%-90.64K | -788.41%-355.32K | -1,443.95%-192.67K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 158.54%28.99K | 1,516,500.00%15.16K | 0 | 7.56%-49.52K | 100.00%-1 | ||||
Net PPE purchase and sale | --0 | ---- | ---- | --0 | -1,382,300.00%-13.82K | --0 | ---- | ---- | 7.56%-49.52K | 100.00%-1 |
Net other investing changes | ---- | ---- | ---- | --28.99K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | ---- | ---- | 158.54%28.99K | 1,516,500.00%15.16K | --0 | ---- | ---- | 7.56%-49.52K | 100.00%-1 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 0.00%6.44K | -59.45%181.44K | 874.34%175K | |||||
Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 0.00%6.44K | 81.44%181.44K | --175K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 0.00%6.44K | -59.45%181.44K | 874.34%175K |
Net cash flow | ||||||||||
Beginning cash position | -90.64%2.77K | -77.98%15.48K | -83.02%27.33K | -58.12%160.96K | -92.03%14.27K | -83.42%29.62K | -74.97%70.32K | -58.12%160.96K | 1,159.45%384.36K | -61.39%179.13K |
Current changes in cash | 82.96%-2.62K | 68.76%-12.71K | 86.93%-11.84K | 40.18%-133.63K | 171.87%13.06K | -3,171.00%-15.36K | 60.23%-40.7K | 12.34%-90.64K | -163.14%-223.4K | 77.16%-18.17K |
End cash Position | -98.91%156 | -90.64%2.77K | -77.98%15.48K | -83.02%27.33K | -83.02%27.33K | -92.03%14.27K | -83.42%29.62K | -74.97%70.32K | -58.12%160.96K | -58.12%160.96K |
Free cash from | 82.96%-2.62K | 76.68%-12.71K | 86.93%-11.84K | 59.83%-162.62K | 98.91%-2.11K | ---15.36K | 46.72%-54.52K | 17.48%-90.64K | -332.70%-404.84K | -238.32%-192.67K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.